Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mark Breidenbach's Stock Ratings
Oppenheimer Analyst
Mark Breidenbach is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Overall Average Return
0.66%
Smart Score
Overall Average Return Percentile
38th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/04/2024 | NRIX | Buy Now | Nurix Therapeutics | $11.30 | 165.49% | Mark Breidenbach47% | $27 → $30 | Maintains | Outperform | Get Alert |
| 08/14/2024 | NRIX | Buy Now | Nurix Therapeutics | $11.30 | 138.94% | Mark Breidenbach47% | $25 → $27 | Maintains | Outperform | Get Alert |
| 05/21/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.30 | 900% | Mark Breidenbach47% | $14 → $13 | Maintains | Outperform | Get Alert |
| 12/13/2023 | EPIX | Buy Now | ESSA Pharma | $1.71 | 892.12% | Mark Breidenbach47% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 09/11/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Mark Breidenbach47% | $14 → $22 | Maintains | Outperform | Get Alert |
| 08/09/2023 | EPIX | Buy Now | ESSA Pharma | $1.71 | 892.12% | Mark Breidenbach47% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | ARVN | Buy Now | Arvinas | $7.38 | 1187.26% | Mark Breidenbach47% | → $95 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2023 | IMRX | Buy Now | Immuneering | $2.75 | 810.75% | Mark Breidenbach47% | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 08/03/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.30 | 2053.85% | Mark Breidenbach47% | → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 06/26/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.30 | 2053.85% | Mark Breidenbach47% | → $28 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Mark Breidenbach47% | → $14 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | CUE | Buy Now | Cue Biopharma | $0.64 | 1472.08% | Mark Breidenbach47% | → $10 | Assumes | Outperform → Outperform | Get Alert |
| 06/26/2023 | EPIX | Buy Now | ESSA Pharma | $1.71 | 892.12% | Mark Breidenbach47% | → $17 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | IMRX | Buy Now | Immuneering | $2.75 | 810.75% | Mark Breidenbach47% | → $25 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | MCRB | Buy Now | Seres Therapeutics | $7.63 | 57.27% | Mark Breidenbach47% | → $12 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | ARVN | Buy Now | Arvinas | $7.38 | 1187.26% | Mark Breidenbach47% | → $95 | Assumes | → Outperform | Get Alert |
| 06/26/2023 | NRIX | Buy Now | Nurix Therapeutics | $11.30 | 121.24% | Mark Breidenbach47% | → $25 | Assumes | → Outperform | Get Alert |
| 05/25/2023 | BLRX | Buy Now | BioLine Rx | $4.41 | -9.3% | Mark Breidenbach47% | → $4 | Reiterates | → Outperform | Get Alert |
| 05/16/2023 | GMDA | Buy Now | Gamida Cell | — | — | Mark Breidenbach47% | $8 → $6 | Maintains | Outperform | Get Alert |
| 05/16/2023 | CGEN | Buy Now | Compugen | $1.65 | 324.24% | Mark Breidenbach47% | $8 → $7 | Maintains | Outperform | Get Alert |
| 05/08/2023 | ARVN | Buy Now | Arvinas | $7.38 | 1187.26% | Mark Breidenbach47% | → $95 | Reiterates | → Outperform | Get Alert |
| 03/28/2023 | GMDA | Buy Now | Gamida Cell | — | — | Mark Breidenbach47% | $10 → $8 | Maintains | Outperform | Get Alert |
| 03/24/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Mark Breidenbach47% | → $14 | Reiterates | → Outperform | Get Alert |
| 03/22/2023 | CUE | Buy Now | Cue Biopharma | $0.64 | 1472.08% | Mark Breidenbach47% | → $10 | Reiterates | → Outperform | Get Alert |
| 03/10/2023 | CRBU | Buy Now | Caribou Biosciences | $1.31 | 2342.75% | Mark Breidenbach47% | $36 → $32 | Maintains | Outperform | Get Alert |
| 03/03/2023 | SYRS | Buy Now | Syros Pharmaceuticals | $0.02 | 53004.58% | Mark Breidenbach47% | $15 → $13 | Maintains | Outperform | Get Alert |
| 03/01/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 644.42% | Mark Breidenbach47% | $25 → $15 | Maintains | Outperform | Get Alert |
| 03/01/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.30 | 2053.85% | Mark Breidenbach47% | $32 → $28 | Maintains | Outperform | Get Alert |
| 02/28/2023 | CGEN | Buy Now | Compugen | $1.65 | 384.85% | Mark Breidenbach47% | → $8 | Reiterates | → Outperform | Get Alert |
| 02/28/2023 | NRIX | Buy Now | Nurix Therapeutics | $11.30 | 121.24% | Mark Breidenbach47% | → $25 | Initiates | → Outperform | Get Alert |
| 11/15/2022 | SYRS | Buy Now | Syros Pharmaceuticals | $0.02 | 61174.51% | Mark Breidenbach47% | $30 → $15 | Maintains | Outperform | Get Alert |
| 11/15/2022 | GMDA | Buy Now | Gamida Cell | — | — | Mark Breidenbach47% | $15 → $10 | Maintains | Outperform | Get Alert |
| 11/15/2022 | CGEN | Buy Now | Compugen | $1.65 | 384.85% | Mark Breidenbach47% | $12 → $8 | Maintains | Outperform | Get Alert |
| 10/25/2022 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Mark Breidenbach47% | $17 → $14 | Maintains | Outperform | Get Alert |
| 10/18/2022 | SYBX | Buy Now | Synlogic | $1.18 | 577.97% | Mark Breidenbach47% | $6 → $8 | Maintains | Outperform | Get Alert |
| 09/02/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | Mark Breidenbach47% | — | Downgrade | Outperform → Perform | Get Alert |
| 08/24/2022 | CUE | Buy Now | Cue Biopharma | $0.64 | 1472.08% | Mark Breidenbach47% | $26 → $10 | Maintains | Outperform | Get Alert |
| 08/10/2022 | ALLO | Buy Now | Allogene Therapeutics | $1.30 | 2592.31% | Mark Breidenbach47% | $40 → $35 | Maintains | Outperform | Get Alert |
| 08/10/2022 | SYRS | Buy Now | Syros Pharmaceuticals | $0.02 | 12154.9% | Mark Breidenbach47% | $9 → $3 | Maintains | Outperform | Get Alert |
| 08/08/2022 | CGEN | Buy Now | Compugen | $1.65 | 627.27% | Mark Breidenbach47% | $14 → $12 | Maintains | Outperform | Get Alert |
| 08/08/2022 | ARVN | Buy Now | Arvinas | $7.38 | 1282.11% | Mark Breidenbach47% | $108 → $102 | Maintains | Outperform | Get Alert |
| 05/27/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 1239.95% | Mark Breidenbach47% | $31 → $27 | Maintains | Outperform | Get Alert |
| 05/13/2022 | SYBX | Buy Now | Synlogic | $1.18 | 408.47% | Mark Breidenbach47% | $7 → $6 | Maintains | Outperform | Get Alert |
| 04/01/2022 | IMRX | Buy Now | Immuneering | $2.75 | 810.75% | Mark Breidenbach47% | → $25 | Initiates | → Outperform | Get Alert |
| 03/21/2022 | CUE | Buy Now | Cue Biopharma | $0.64 | 3987.41% | Mark Breidenbach47% | $32 → $26 | Maintains | Outperform | Get Alert |
| 02/25/2022 | CGEN | Buy Now | Compugen | $1.65 | 748.48% | Mark Breidenbach47% | $17 → $14 | Maintains | Outperform | Get Alert |
| 02/24/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Mark Breidenbach47% | $92 → $86 | Maintains | Outperform | Get Alert |
| 12/01/2021 | CRBU | Buy Now | Caribou Biosciences | $1.31 | 2648.09% | Mark Breidenbach47% | → $36 | Initiates | → Outperform | Get Alert |
| 11/24/2021 | SYBX | Buy Now | Synlogic | $1.18 | — | Mark Breidenbach47% | — | Upgrade | Perform → Outperform | Get Alert |
| 11/16/2021 | GMDA | Buy Now | Gamida Cell | — | — | Mark Breidenbach47% | $17 → $15 | Maintains | Outperform | Get Alert |
| 08/17/2021 | EPIX | Buy Now | ESSA Pharma | $1.71 | 1183.92% | Mark Breidenbach47% | $36 → $22 | Maintains | Outperform | Get Alert |
| 07/23/2021 | MCRB | Buy Now | Seres Therapeutics | $7.63 | 135.91% | Mark Breidenbach47% | $36 → $18 | Maintains | Outperform | Get Alert |
| 07/23/2021 | ARVN | Buy Now | Arvinas | $7.38 | 1363.41% | Mark Breidenbach47% | $100 → $108 | Maintains | Outperform | Get Alert |
| 07/19/2021 | KDMN | Buy Now | Kadmon Holdings | — | — | Mark Breidenbach47% | $8 → $9 | Maintains | Outperform | Get Alert |
| 05/24/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 1785.86% | Mark Breidenbach47% | $51 → $38 | Maintains | Outperform | Get Alert |
| 05/19/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 2431.02% | Mark Breidenbach47% | $57 → $51 | Maintains | Outperform | Get Alert |
| 04/26/2021 | ACHL | Buy Now | Achilles Therapeutics | — | — | Mark Breidenbach47% | → $23 | Initiates | → Outperform | Get Alert |
| 05/20/2020 | CUE | Buy Now | Cue Biopharma | $0.64 | 4930.66% | Mark Breidenbach47% | $27 → $32 | Maintains | Outperform | Get Alert |
| 05/12/2020 | MBIO | Buy Now | Mustang Bio | $1.10 | 1082.03% | Mark Breidenbach47% | $15 → $13 | Maintains | Outperform | Get Alert |
| 05/12/2020 | ARVN | Buy Now | Arvinas | $7.38 | — | Mark Breidenbach47% | — | Initiates | → Perform | Get Alert |
| 05/07/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Mark Breidenbach47% | $88 → $101 | Maintains | Outperform | Get Alert |
| 03/31/2020 | MCRB | Buy Now | Seres Therapeutics | $7.63 | -8.26% | Mark Breidenbach47% | $8 → $7 | Maintains | Outperform | Get Alert |
| 02/26/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 1636.97% | Mark Breidenbach47% | $32 → $35 | Reiterates | → Outperform | Get Alert |
| 02/25/2020 | CUE | Buy Now | Cue Biopharma | $0.64 | 4144.62% | Mark Breidenbach47% | → $27 | Initiates | → Outperform | Get Alert |
| 12/13/2019 | BLUE | Buy Now | bluebird bio | — | — | Mark Breidenbach47% | → $135 | Upgrade | Perform → Outperform | Get Alert |
| 10/25/2019 | EPIX | Buy Now | ESSA Pharma | $1.71 | 366.88% | Mark Breidenbach47% | → $8 | Initiates | → Outperform | Get Alert |
| 08/21/2019 | SYBX | Buy Now | Synlogic | $1.18 | — | Mark Breidenbach47% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/26/2019 | KDMN | Buy Now | Kadmon Holdings | — | — | Mark Breidenbach47% | → $6 | Initiates | → Outperform | Get Alert |
| 05/08/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | Mark Breidenbach47% | $79 → $74 | Maintains | Outperform | Get Alert |
| 03/29/2018 | CGEN | Buy Now | Compugen | $1.65 | 445.45% | Mark Breidenbach47% | → $9 | Initiates | → Outperform | Get Alert |
| 01/31/2018 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 842.93% | Mark Breidenbach47% | $13 → $19 | Maintains | Outperform | Get Alert |
| 12/21/2017 | MBIO | Buy Now | Mustang Bio | $1.10 | 1536.66% | Mark Breidenbach47% | → $18 | Initiates | → Outperform | Get Alert |
| 12/21/2017 | BLUE | Buy Now | bluebird bio | — | — | Mark Breidenbach47% | — | Initiates | → Perform | Get Alert |
| 12/13/2017 | ADRO | Buy Now | Aduro Biotech | — | — | Mark Breidenbach47% | $15 → $13 | Maintains | Outperform | Get Alert |
| 11/15/2017 | SRNE | Buy Now | Sorrento Therapeutics | $0.00 | 285614.29% | Mark Breidenbach47% | $7 → $6 | Maintains | Outperform | Get Alert |
| 10/13/2017 | MCRB | Buy Now | Seres Therapeutics | $7.63 | 149.02% | Mark Breidenbach47% | → $19 | Initiates | → Outperform | Get Alert |
| 08/04/2017 | SRNE | Buy Now | Sorrento Therapeutics | $0.00 | 333233.33% | Mark Breidenbach47% | → $7 | Initiates | → Outperform | Get Alert |
| 08/04/2017 | IOVA | Buy Now | Iovance Biotherapeutics | $2.02 | 545.16% | Mark Breidenbach47% | → $13 | Initiates | → Outperform | Get Alert |
| 08/04/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | Mark Breidenbach47% | → $53 | Initiates | → Outperform | Get Alert |
| 04/20/2017 | MATN | Buy Now | Mateon Therapeutics | — | — | Mark Breidenbach47% | → $2 | Initiates | → Buy | Get Alert |
| 02/01/2016 | CGEN | Buy Now | Compugen | $1.65 | — | Mark Breidenbach47% | — | Assumes | — | Get Alert |
| 12/01/2015 | ADRO | Buy Now | Aduro Biotech | — | — | Mark Breidenbach47% | — | Downgrade | Outperform → Perform | Get Alert |
| 10/20/2015 | ADRO | Buy Now | Aduro Biotech | — | — | Mark Breidenbach47% | → $30 | Initiates | → Outperform | Get Alert |
| 10/20/2015 | BLUE | Buy Now | bluebird bio | — | — | Mark Breidenbach47% | → $162 | Initiates | → Outperform | Get Alert |
| 10/19/2015 | ADRO | Buy Now | Aduro Biotech | — | — | Mark Breidenbach47% | → $30 | Initiates | → Outperform | Get Alert |
| 04/21/2015 | CGEN | Buy Now | Compugen | $1.65 | 566.67% | Mark Breidenbach47% | → $11 | Initiates | → Outperform | Get Alert |
